Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
2 other identifiers
observational
371
1 country
2
Brief Summary
The purpose of this study to evaluate peer-led mutual help organizations (MHOs) that target individuals with psychiatric diagnoses such as mood disorders, and provide evidence either supporting the expansion of such groups and the development and testing of clinical procedures, or point toward reevaluation and development of alternative low-cost, community based approaches to promoting recovery among individuals suffering from these disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2014
CompletedFirst Posted
Study publicly available on registry
September 17, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedAugust 29, 2017
August 1, 2017
2.4 years
August 18, 2014
August 28, 2017
Conditions
Outcome Measures
Primary Outcomes (3)
Systematically gather empirical estimates of the characteristics of current DBSA participants through a cross-sectional survey of demographics, clinical service, and past and current DBSA attendance, involvement, and subjective benefits.
The goal is to describe and characterize DBSA participants and obtain information on subjective benefits.
Up to 24 months
Provide estimates of rates of attendance, retention in, and discontinuation from DBSA for new DBSA members with mood disorders.
Determine which DBSA participants are more likely to attend more frequently/become more engaged.
Up to 24 months
Conduct a prospective between-group investigation comparing new DBSA members to a matched control group with no prior exposure to DBSA in order to test for beneficial affects of DBSA over a 6-month follow up.
Compare new DBSA members to a matched control group in order to test for any potential incremental beneficial effects from DBSA participation.
Up to 24 months
Study Arms (3)
AIM 1
200 current DBSA participants.
AIM 2
60 new DBSA attendees with mood disorders who have attended their first meeting in the past month.
AIM 3
100 matched control group individuals with mood disorders with no current or prior exposure to DBSA.
Eligibility Criteria
We will recruit participants from a large DBSA chapter at McLean Hospital. Subjects will be recruited at the beginning of the weekly meetings, through flyers, the DBSA website, and word of mouth. 200 current DBSA members and 60 new DBSA members will be assessed for Aims 1 and 2, respectively. 100 people who have never attended a DBSA will be assessed for Aim 3 and will be recruited from MGH and McLean Hospitals through the use of flyers, clinic announcements, and via our online clinical and research infrastructures. Participants in all Aims must be 18 years or older and self-report a diagnosis of any type of mood disorder. For Aims 1 and 2, participants must have attended at least one DBSA meeting.
You may qualify if:
- Aim 1:
- years of age or older
- Self-report a diagnosis of any type of mood disorder
- Attend DBSA meetings
- Aim 2:
- years of age or older
- Self-report a diagnosis of any type of mood disorder
- Have attended their first meeting in the past month
- Aim 3:
- years of age or older
- Self-report a diagnosis of any type of mood disorder
- Have never attended a DBSA meeting
You may not qualify if:
- Aim 1:
- Do not report a diagnosis of any type of mood disorder
- Have not attended a DBSA meeting
- Aim 2:
- Do not report a diagnosis of any type of mood disorder
- Have not attended a DBSA meeting
- Have attended their first meeting prior to a month before their assessment
- Aim 3:
- Do not report a diagnosis of any type of mood disorder
- Have attended a DBSA meeting
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
McLean Hospital
Belmont, Massachusetts, 02478, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John F Kelly, PhD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Psychiatry Harvard Medical School
Study Record Dates
First Submitted
August 18, 2014
First Posted
September 17, 2014
Study Start
November 1, 2014
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
August 29, 2017
Record last verified: 2017-08